• FDA DYMISTA NDA 202236 approval records — 22 FDA documents, 848 pages
1 1

FDA 510(k) K193483, Basal-IQ Technology, by Tandem Diabetes Care, Inc.

FDA 510(k) K193483, Basal-IQ Technology, by Tandem Diabetes Care, Inc.

$2,635.88 USD
$2,635.88 USD
Sale Sold out

510(K) Number: K193483
Device Name: Basal-IQ Technology
Manufacturer: Tandem Diabetes Care, Inc.
Device Classification Name: Interoperable Automated Glycemic Controller, Insulin Suspend
Regulation Number: 862.1356
Classification Product Code: QJS
Date Received: 12/17/2019
Decision Date: 02/28/2020
Regulation Medical Specialty: Clinical Chemistry

1,554 pages (2,749 of 4,303 original pages are fully redacted)
View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome